Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OP 801 - Orpheris

Next Previous
Drug Profile

OP 801 - Orpheris

Alternative Names: 18F OP 801; OP-801; PET Dendrimer

Latest Information Update: 28 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ashvattha Therapeutics
  • Developer Ashvattha Therapeutics; Orpheris
  • Class Dendrimers; Diagnostic agents; Imaging agents
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Alzheimer's disease; Amyotrophic lateral sclerosis; Multiple sclerosis; Parkinson's disease
  • No development reported Neurological disorders

Most Recent Events

  • 28 Jan 2025 No recent reports of development identified for preclinical development in Neurological-disorders(Diagnosis) in USA
  • 10 Jun 2024 Pharmacodynamics data from a preclinical study in Multiple sclerosis released by Ashvattha Therapeutics
  • 01 Feb 2024 Phase-I/II clinical trials in Alzheimer's disease (Diagnosis) in USA (IV) (NCT05395624)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top